Cargando…

Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics

The primary objective was to create and establish a new formula that predicts the individual probability of macular hole closure for eyes with full thickness macular holes (FTMH) accompanied by vitreomacular traction (VMT) which received enzymatic vitreolysis using intravitreally administered ocripl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertelmann, Thomas, Berndzen, Lars, Raber, Thomas, Pfeiffer, Sebastian, Leha, Andreas, Paul, Christoph, Feltgen, Nicolas, Bemme, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677762/ https://www.ncbi.nlm.nih.gov/pubmed/34916576 http://dx.doi.org/10.1038/s41598-021-03509-z

Ejemplares similares

Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction–Validation and refinement of a multivariable prediction model
por: Paul, Christoph, et al.
Publicado: (2022)

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016)

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016)

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014)

Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
por: Arrigo, Alessandro, et al.
Publicado: (2020)

Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
por: Muqit, Mahiul M. K., et al.
Publicado: (2018)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020)

Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment
por: Liang, I-Chia, et al.
Publicado: (2016)

Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
por: Iuliano, Lorenzo, et al.
Publicado: (2019)

Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction
por: Rossi, Settimio, et al.
Publicado: (2016)

Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
por: Katsanos, Andreas, et al.
Publicado: (2020)

Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study
por: Mastropasqua, Rodolfo, et al.
Publicado: (2016)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
por: Furino, Claudio, et al.
Publicado: (2020)

ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial
por: Tadayoni, Ramin, et al.
Publicado: (2019)

Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature
por: Lescrauwaet, Benedicte, et al.
Publicado: (2019)

Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies
por: Joondeph, Brian C., et al.
Publicado: (2021)

Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
por: Rosati, Alessandra, et al.
Publicado: (2018)

Pneumatic Vitreolysis With Intravitreal Air for Focal Vitreomacular Traction
por: Seamone, Mark E., et al.
Publicado: (2020)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
por: Casswell, Edward, et al.
Publicado: (2014)

Myopic macular hole detachment associated with intravitreal ocriplasmin
por: Goh, Li Yen, et al.
Publicado: (2020)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

Redesigning services for the management of vitreomacular traction and macular hole
por: Amoaku, W, et al.
Publicado: (2014)

Apparent double macular hole caused by vitreomacular traction
por: Babu, Naresh, et al.
Publicado: (2020)

Surgical Outcome of Vitreomacular Traction Associated With Macular Hole
por: Tayyab, Mashal, et al.
Publicado: (2022)

A Review of Current Management of Vitreomacular Traction and Macular Hole
por: García-Layana, Alfredo, et al.
Publicado: (2015)

An Assessment of Vitreous Degeneration in Eyes with Vitreomacular Traction and Macular Holes
por: Ghadiali, Quraish, et al.
Publicado: (2017)

Incidence and prevalence of vitreomacular traction with and without macular hole in Germany
por: Menzler, Jacob, et al.
Publicado: (2019)

Vitreomacular Traction Syndrome
por: Bottós, Juliana, et al.
Publicado: (2012)

Vitreomacular traction syndrome
por: Martins, Thiago Gonçalves dos Santos, et al.
Publicado: (2015)

Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
por: Song, Su Jeong, et al.
Publicado: (2014)

Spontaneous Closure of a Full-Thickness Macular Hole Associated with Proliferative Diabetic Retinopathy and Persistent Vitreomacular Traction
por: Reinherz, Benjamin J., et al.
Publicado: (2016)

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY
por: Mein, Calvin, et al.
Publicado: (2020)

Macular hole formation and spontaneous closure after vitrectomy for vitreomacular traction documented in spectral-domain optical coherence tomography
por: Odrobina, Dominik, et al.
Publicado: (2014)

Vitreomacular traction associated with papillitis
por: Haq, Zeeshan, et al.
Publicado: (2020)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
por: Petrou, Petros, et al.
Publicado: (2013)

INTRAVITREAL INJECTION OF PERFLUOROPROPANE IS MORE EFFICACIOUS THAN SULFUR HEXAFLUORIDE IN RELEASING VITREOMACULAR TRACTION
por: Čokl, Neža, et al.
Publicado: (2018)

An Uncommon Aflibercept Side Effect: Full Thickness Macular Hole Formation After Intravitreal Injections in Patients With Pre-existing Vitreomacular Traction
por: Karamitsos, Athanasios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67niouh9vl5dnmq0eegn52g95a